humanin
Regeneration vs degeneration — where this fits
The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.
What it is
Discusses humanin variants and their aggregation into fibrils with varying cytotoxicity. 2024 study linking Humanin variant P3S to longevity in APOE4 carriers.
How it works
From preclinical claims (animal/lab — not human proof):
- Discusses humanin variants and their aggregation into fibrils with varying cytotoxicity.
- 2024 study linking Humanin variant P3S to longevity in APOE4 carriers.
- Shows humanin produced by macrophages has pro-resolving properties.
- Humanin attenuates atrial fibrillation via anti-fibrotic and mitochondrial effects.
- 2025 review on Humanin (HN) as autophagy inducer for metabolic disorders therapy.
- 2025 review detailing Humanin's molecular neuroprotective effects in AD.
Why it would work (logic chain)
- IF Discusses humanin variants and their aggregation into fibrils with varying cytotoxicity. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF 2024 study linking Humanin variant P3S to longevity in APOE4 carriers. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF Shows humanin produced by macrophages has pro-resolving properties. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF Humanin attenuates atrial fibrillation via anti-fibrotic and mitochondrial effects. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF Examines humanin levels in PCOS patients. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
- IF 2025 review on Humanin (HN) as autophagy inducer for metabolic disorders therapy. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
How many people take it
There is no reliable global count of how many people take this compound. That number is not in this ledger.
What we can count from this ledger:
- 0 anecdote source(s) (posts, threads, comments)
- 0 anecdote-tier claim(s) derived from them
Logic: Without catalogued Reddit/X posts, this article cannot answer how many people take it — only what studies exist.
Evidence inventory
This is a count of what is in this ledger — not a claim about all research worldwide.
- Scientific sources catalogued (PubMed, trials, reviews): 15
- Claims tagged human evidence: 1
- Claims tagged preclinical (animal/lab): 14
- Claims tagged anecdotal: 0
- Reddit posts catalogued: 0
- X posts catalogued: 0
- Other anecdote sources (YouTube, Instagram, etc.): 0
- Total sources in chain: 15
Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.
Quantified confidence (this ledger): 0.93 / 1.00 — moderate — human claims present in ledger
Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.
What scientists say
A Review on the Potential Role of Humanin Peptide and its Analogs in the Regulation of Autophagy Pathways for Therapeutic Application in Metabolic Disorders (source s1)
2025 review on Humanin (HN) as autophagy inducer for metabolic disorders therapy.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
The neuroprotective role of Humanin in Alzheimer's disease: The molecular effects (source s2)
2025 review detailing Humanin's molecular neuroprotective effects in AD.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Humanin improves bone health in a glucocorticoid-treated mouse model (source s3)
2026 study showing Humanin (HNG) prevents glucocorticoid-induced bone issues in mice.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Humanin attenuates metabolic, toxic, and traumatic neuropathic pain in mice by protecting against oxidative stress and increasing inflammatory cytokine ... (source s4)
2025 study on Humanin reducing neuropathic pain via oxidative stress protection in mice.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Humanin variant P3S is associated with longevity in APOE4 carriers (source s5)
2024 study linking Humanin variant P3S to longevity in APOE4 carriers.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Humanin variants aggregate to produce different fibril structures with distinct cytotoxicity (source s6)
Discusses humanin variants and their aggregation into fibrils with varying cytotoxicity.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Insights into the Biomarker Potential of Humanin and Mots-c in Metabolic and Neurodegenerative Diseases (source s7)
Reviews biomarker potential of humanin and MOTS-c in diseases.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
HUMANIN produced by human efferocytic macrophages promotes inflammation resolution (source s8)
Shows humanin produced by macrophages has pro-resolving properties.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Redox-sensitive miRNAs and Humanin could mediate the metabolic benefits of crocin and astaxanthin in type 2 diabetes (source s9)
Links humanin to benefits of antioxidants in T2DM.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction (source s10)
Humanin attenuates atrial fibrillation via anti-fibrotic and mitochondrial effects.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Mediterranean diet adherence is associated with mitochondrial microproteins Humanin and SHMOOSE (source s11)
Associates humanin levels with Mediterranean diet adherence and cardioprotection.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Circulating Humanin Improves the Prognostic Accuracy of Cardiovascular Mortality and Morbidity Prediction (source s12)
Humanin as prognostic biomarker for cardiovascular outcomes.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Mitochondrial-derived peptides MOTS-c and humanin attenuate glucocorticoid-induced muscle atrophy (source s13)
Humanin and MOTS-c protect against glucocorticoid-induced muscle wasting.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome (source s14)
Examines humanin levels in PCOS patients.
Evidence type: Tagged human evidence in this ledger — check sample size and design.
Mitochondrial-Derived Peptides as Therapeutics and Biomarkers in Vascular Diseases (source s15)
Review on humanin as therapeutic and biomarker in vascular disease.
Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.
Safety and limits
- Discusses humanin variants and their aggregation into fibrils with varying cytotoxicity.
---
Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.
Evidence ledger 15 · tier-ranked · API
10 more ranked claims
Ask this article · 8 suggested prompts
Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.